https://www.selleckchem.com/pr....oducts/pf-562271.htm
lity observed within subjects. Second, we found that differences in prioritizing effort versus stability explained differences in the postural response as well as differences in trial-by-trial variability across subjects. Patients with refractory Mycobacterium avium complex (MAC) lung disease have limited treatment options. In the CONVERT study, amikacin liposome inhalation suspension (ALIS) added to guideline-based therapy (GBT) increased culture conversion rates vs GBT alone by Month 6. Limited data are available regarding 6-mon
Like
Comment
Share
